实用临床医药杂志2023，Vol.27Issue(17)：88-92,5.DOI:10.7619/jcmp.20231325
思力华联合信必可治疗慢性阻塞性肺疾病合并肺心病的效果观察
Effect of Spirva combined with Symbicort in treatment of chronic obstructive pulmonary disease patients complicated with pulmonary heart disease
摘要
关键词
慢性阻塞性肺疾病/肺心病/噻托溴铵粉吸入剂/布地奈德福莫特罗吸入剂/肺功能/肺动脉压/炎症因子Key words
chronic obstructive pulmonary disease/pulmonary heart disease/Tiotropium Bromide Powder Inhalant/Budesonide/Formoterol Inhalant/lung function/pulmonary artery pres-sure/inflammatory factors分类
医药卫生引用本文复制引用
冯文萍,宫志鹏,姚雪婷,赵茜茜,李新鹏,李有香..思力华联合信必可治疗慢性阻塞性肺疾病合并肺心病的效果观察[J].实用临床医药杂志,2023,27(17):88-92,5.基金项目
河北省张家口市重点研发计划项目(1921094D) （1921094D）
